• Tyrosine hydroxylase;
  • Alternative splicing;
  • Neuroblastoma;
  • Human;
  • Peptide antibodies;
  • Catecholamines


  1. Top of page
  2. Abstract

Abstract: Human tyrosine hydroxylase (HTH) RNA undergoes alternative splicing, and four different forms of HTH mRNA have been previously identified. Rabbit antibodies were raised against octapeptides unique to each of the four isoforms of HTH predicted from these mRNAs. Blot immunolabeling of human adrenal medulla, pheochromocytoma, and several neuroblastoma cell lines with affinitypurified anti-HTH peptide antibodies demonstrated the presence of all four HTH isoforms in each of these tissues. Quantitative immunolabeling assays for HTH-1, -2, and -4 were established, and HTH isoform levels were determined in several human neuroblastoma cell lines. Whereas total HTH levels differed up to fourfold among the HTH-positive neuroblastoma cell lines studied [LA-N-1, LA-N-5, CHP-234, BE(2)-C, and BE(2)-M17], the relative abundances of HTH isoforms in each of the cell lines were similar. Immunocytochemical analyses demonstrated that HTH immunoreactivity was distributed unequally among the cells in each of these neuroblastoma lines, and morphological interconversion did not account for this heterogeneity. A direct relationship between the percentage of HTH-positive cells and overall HTH levels was also observed. This relationship, in the absence of an apparent clonal basis for the heterogeneity, suggests that HTH expression in neuroblastoma cells may be controlled in a relatively “all-ornone”(bimodal) fashion.

Abbreviations Used:

HTH, and RTH, bovine, human, and rat tyrosine hydroxylase, respectively


human tyrosine hydroxylase mRNA


mouse monoclonal and rabbit polyclonal antibodies to sodium dodecyl sulfate-denatured rat tyrosine hydroxylase


nickel-enhanced diaminobenzidine


polyacrylamide gel electrophoresis


Dulbecco's phosphate-buffered, divalent-deficient saline

rHTH and rRTH

recombinant human and rat tyrosine hydroxylase, respectively


sodium dodecyl sulfate


  1. Top of page
  2. Abstract
  • Chandler C. E., Cragoe E. J., and Glaser L. (1985) Nerve growth factor does not activate Na+/H+ exchange in PC12 pheochromocytoma cells. J. Cell. Physiol. 125, 367378.
  • Coker G. T. III, Studelska D., Harmon S., Burke W., and O'Malley K. L. (1990) Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Mol. Brain Res. 8, 9398.
  • Czernik A. J., Girault J.-A., Nairn A. C., Chen J., Snyder G., Kebabian J., and Greengard P. (1991) Production of phosphorylation state-specific antibodies. Methods Enzymol. 201, 264283.
  • Fitzpatrick P. F., Chlumsky L. J., Daubner S. C., and O'Malley K. L. (1990) Expression of rat tyrosine hydroxylase in insect tissue culture cells and purification and characterization of the cloned enzyme. J. Biol. Chem. 265, 20422047.
  • Girault J.-A., Raisman-Vozari R., Agid Y., and Greengard P. (1989) Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy. Proc. Natl. Acad. Sci. USA 86, 24932497.
  • Grima B., Lamouroux A., Boni C., Julien J.-F., Javoy-Agid F., and Mallet J. (1987) A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 326, 707711.
  • Haavik J., Le Bourdellès B., Martinez A., Flatmark T., and Mallet J. (1991) Recombinant human tyrosine hydroxylase, isozymes. Reconstitution with iron and inhibitory effect of other metal ions. Eur. J. Biochem. 199, 371378.
  • Hammarback J. A. and Vallee R. B. (1990) Antibody exchange immunochemistry. J. Biol. Chem. 265, 1276312766.
  • Harlow E. and Lane D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor , New York .
  • Haycock J. W. (1989) Quantitation of tyrosine hydroxylase protein levels: spot immunolabeling with an affinity-purified antibody. Anal. Biochem. 181, 259266.
  • Haycock J. W. (1990) Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31 and 40. J. Biol. Chem. 265, 1168211691.
  • Haycock J. W. (1991) Four forms of tyrosine hydroxylase are present in human adrenal medulla. J. Neurochem. 56, 21392142.
  • Haycock J. W. (1993) Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40. Neurochem. Res. 18, 1526.
  • Haycock J. W. and Moses R. L. (1992) Reproduction of gels and autoradiograms with contact negatives and prints. Biotechnology 12, 378.
  • Kaneda N., Kobayashi K., Ichinose H., Kishi F., Nakazawa A., Kurosawa Y., Fujita K., and Nagatsu T. (1987) Isolation of a novel cDNA clone for human tyrosine hydroxylase: alternative RNA splicing produces four kinds of mRNA from a single gene. Biochem. Biophys. Res. Commun. 146, 971975.
  • Kilbourne E. J., Osaka H., and Sabban E. L. (1991) Hypomethylation of the rat tyrosine hydroxylase gene correlates with its expression in several cell types. Dev. Brain Res. 58, 143146.
  • Kobayashi K., Kaneda N., Ichinose H., Kishi F., Nakazawa A., Kurosawa Y., Fujita K., and Nagatsu T. (1987) Isolation of a full length cDNA clone encoding human tyrosine hydroxylase type 3. Nucleic Acids Res. 15, 6733.
  • Kojima K., Mogi M., Oka K., and Nagatsu T. (1984) Purification and immunochemical characterization of human adrenal tyrosine hydroxylase. Neurochem. Int. 6, 475480.
  • Le Bourdellès B., Boularand S., Boni C., Horellou P., Dumas S., Grima B., and Mallet J. (1988) Analysis of the 5′ region of the human tyrosine hydroxylase gene: combinatorial patterns of exon splicing generate multiple regulated tyrosine hydroxylase isoforms. J. Neurochem. 50, 988991.
  • Le Bourdellès B., Horellou P., Le Caer, J.-P., Denèfle P., Latta M., Haavik J., Guibert B., Mayaux J.-F., and Mallet J. (1991) Phosphorylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: an additional phosphorylated residue in isoform 2, generated through alternative splicing. J. Biol. Chem. 266, 1712417130.
  • Lewis D. A., Melchitzky D. S., and Haycock J. W. (1993) Four isoforms of tyrosine hydroxylase are expressed in human brain. Neuroscience (in press).
  • Mogi M., Kojima K., and Nagatsu T. (1984) Detection of inactive or less active forms of tyrosine hydroxylase in human adrenals by a sandwich enzyme immunoassay. Anal. Biochem. 138, 125132.
  • Mogi M., Kojima K., Harada M., and Nagatsu T. (1986) Purification and immunochemical properties of tyrosine hydroxylase in human brain. Neurochem. Int. 8, 423428.
  • Nagatsu T. (1991) Genes for human catecholamine-synthesizing enzymes. Neurosci. Res. 24, 315345.
  • Nagatsu T. and Ichinose H. (1991) Comparative studies on the structure of human tyrosine hydroxylase with those of the enzyme of various mammals. Comp. Biochem. Physiol. [C] 98, 203210.
  • O'Mallcy K. L., Anhalt M. J., Martin B. M., Kelsoe J. R., Winfield S. L., and Ginns E. I. (1987) Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5′ alternative splice sites responsible for multiple mRNAs. Biochemistry 26, 69106914.
  • Pennypacker K. R., Kuhn D. M., and Billingsley M. L. (1989) Changes in expression of tyrosine hydroxylase immunoreactivity in human SMS-KCNR neuroblastoma following retinoic acid or phorbol ester-induced differentiation. Mol. Brain Res. 5, 251258.
  • Rabinovsky E. D., Le W.-D., and McManaman J. L. (1992) Differential effects of neurotrophic factors on neurotransmitter development in the IMR-32 human neuroblastoma cell line. J. Neurosci. 12, 171179.
  • Robinson B. H., Oei J., Saudubray J. M., Marsac C., Bartlett K., Quan F., and Gravel R. (1987) The French and North American phenotype of pyruvate carboxylase deficiency, correlation with biotin containing protein by 3H-biotin incorporation, 35S-streptavidin labeling, and northern blotting. Am. J. Hum. Genet. 40, 5059.
  • Ross R. A., Biedler J. L., Spengler B. A., and Reis D. J. (1981) Neurotransmitter-synthesizing enzymes in 14 human neuroblastoma cell lines. Cell. Mol. Neurobiol. 1, 301312.
  • Salinovich O. and Montelaro R. C. (1986) Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by sodium dodecylsulfate-polyacrylamide gel electrophoresis. Anal. Biochem. 156, 341347.
  • Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., and Klenk D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 7685.
  • Staros J. V., Wright R. W., and Swingle D. M. (1986) Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal. Biochem. 156, 220222.
  • Tsang V. C. W. and Wilkins P. P. (1991) Optimum dissociating condition for immunoaffinity and preferential isolation of antibodies with high specific activity. J. Immunol. Methods 138, 291299.
  • Wolf M. E., LeWitt P. A., Bannon M. J., Dragovic L. J., and Kapatos G. (1991) Effect of aging on tyrosine hydroxylase protein content and the relative number of dopamine nerve terminals in human caudate. J. Neurochem. 56, 11911200.